Back to search

University of Glasgow

Modulation of Anthracycline Activity by a Range of Drug Carriers

Abstract

dc:description.abstract

Major advances in the treatment of leukaemia and lymphoma in the 1960s and 70s led to the euphoric belief that solid tumours would also yield to cytotoxic chemotherapy. Unfortunately this promise has remained largely unfulfilled. Many reasons are cited for this therapeutic failure, but it is generally accepted that drug resistance, either arising 'de novo' or aquired, is a major factor in this problem. The work detailed in this thesis looks at some possible methods of overcoming so-called pharmacological resistance' i.e. drug resistance based on an inability to deliver enough active drug to it's site of action.

Degree

thesis:*
Level dc:type.qualificationlevel
MD
Grantor dc:publisher.institution
University of Glasgow
Year dc:date.issued
1991

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Cassidy, James

Rights

Language dc:language
en

Chain of custody

source
Harvested from
University of Glasgow
Base URL
theses.gla.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Cassidy, James. Modulation of Anthracycline Activity by a Range of Drug Carriers. MD thesis, University of Glasgow, 1991.